Literature DB >> 10810584

Surgical filariasis: immunoscreening for filarial IgG antibodies using Wuchereria bancrofti microfilarial excretory-secretory antigen.

V K Mehta1, H Lohar, G K Banerjee, M V Reddy, B C Harinath.   

Abstract

A clinical study and immunoscreening was conducted on 363 suspected filarial patients attending the surgery out patient division of the MGIMS, Sevegram. The disease was significantly higher in males (86%) than in females (14%). Majority (52.9%) of the cases were in the age group of 11-30 years. The distribution of cases into three different grades of infection showed, 52.6%, 33.3% and 14.1% of the cases having acute (grade I), sub-acute (grade II) and chronic (grade III) stages of infection respectively. While 73% of the cases had genital manifestations, 23% were with lymphatic obstruction in limbs and the rest of the 4% suffered from manifestations like cellulitis, abscesses, haematuria and chyluria. Filarial IgG antibodies against microfilarial excretory-secretory (mf ES) antigen were detected in 89% of cases with genital manifestations, 87% of lymphoedema cases, 67% of lymphadenitis cases and 60% of cases with other clinical manifestations and 3% of endemic normals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10810584

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  4 in total

1.  Crossed fused renal ectopia with chyluria: a rare presentation.

Authors:  Kawaljit Singh; Manoj Kumar; Ankur Jhanwar; Satyanarayan Sankhwar
Journal:  BMJ Case Rep       Date:  2016-01-28

Review 2.  Robotic surgery for treatment of chyluria.

Authors:  Naman Barman; Michael Palese
Journal:  J Robot Surg       Date:  2016-02-09

3.  Cloning and characterization of Clonorchis sinensis myoglobin using immune sera against excretory-secretory antigens.

Authors:  Seobo Sim; Gab-Man Park; Tai-Soon Yong
Journal:  Parasitol Res       Date:  2003-09-16       Impact factor: 2.289

Review 4.  Chyluria: what does the clinician need to know?

Authors:  Victoria Stainer; Patrick Jones; Siri Øvereng Juliebø; Rupert Beck; Amr Hawary
Journal:  Ther Adv Urol       Date:  2020-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.